Cryptocurrency Q&A
What happens to my Mirati stock?
What happens to my Mirati stock?
ShintoMystical
Fri Aug 30 2024
|
7 answers
1713
Hello there, I'm curious about what might happen to my Mirati stock. As an investor, I'm always keeping an eye on the market and trying to stay informed about my holdings. With Mirati Therapeutics being a biotechnology company that specializes in developing treatments for cancer, I'm particularly interested in how their progress and potential new drug approvals might impact the value of my shares. Can you provide some insight into what factors might influence the future performance of Mirati stock? Thank you in advance for your help.
7 answers
ZenBalance
Sun Sep 01 2024
Shareholders of Mirati Therapeutics have experienced a significant transformation following the completion of the merger. As part of the agreement, shareholders received a tangible financial benefit for their investment.
Was this helpful?
90
51
Leonardo
Sun Sep 01 2024
Each Mirati common stock share was exchanged for a cash payment of $58.00, providing immediate liquidity to investors. This amount was paid without any interest, emphasizing the straightforward and direct nature of the transaction.
Was this helpful?
276
49
HallyuHeroLegend
Sun Sep 01 2024
In addition to the cash payment, shareholders also received a Contingent Value Right (CVR). This represents a potential future benefit, contingent on certain events or milestones being met.
Was this helpful?
254
70
DigitalLordGuard
Sun Sep 01 2024
The CVR offers shareholders the opportunity to participate in the future success of the merged entity. It serves as a form of incentive, aligning the interests of shareholders with the long-term goals of the company.
Was this helpful?
321
66
EmilyJohnson
Sat Aug 31 2024
It's important to note that the receipt of both the cash payment and the CVR is subject to any required tax withholding. Investors should consult with their tax advisors to understand the tax implications of the transaction.
Was this helpful?
328
62
Load 5 more related questions
